financetom
Business
financetom
/
Business
/
Nvidia CEO says company not planning to ship anything to China
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia CEO says company not planning to ship anything to China
Nov 6, 2025 11:12 PM

Taipei (Reuters) -Nvidia ( NVDA ) CEO Jensen Huang said on Friday, upon arriving in the city of Tainan for his fourth public visit to Taiwan this year, that the U.S. AI chipmaker did not plan to ship anything to China but hoped to serve the Chinese market again in the future.

Huang, in remarks seen on a live broadcast by Taiwan's Formosa TV News network, said he was in Taiwan to visit long-time partner TSMC and participate in the company's sports day.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
Mar 26, 2025
March 26 (Reuters) - Salarius Pharmaceuticals Inc ( SLRX ) : * SALARIUS PHARMACEUTICALS MERGER PARTNER, DECOY THERAPEUTICS, ANNOUNCES ITS NOVEL INHIBITORS SHOW PROMISING IN SILICO ACTIVITY AGAINST MEASLES AND RELATED VIRUSES Source text: Further company coverage: ...
Ionis Partners With Sobi to Commercialize Familial Chylomicronemia Syndrome Treatment Outside US
Ionis Partners With Sobi to Commercialize Familial Chylomicronemia Syndrome Treatment Outside US
Mar 26, 2025
08:12 AM EDT, 03/26/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said Wednesday it has entered into a license agreement with Sobi that allows it exclusive commercialization rights for olezarsen in countries outside the US, Canada, and China. Olezarsen is a potential treatment for familial chylomicronemia syndrome and severely elevated triglycerides, and was approved by the US Food and...
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump
Mar 26, 2025
08:13 AM EDT, 03/26/2025 (MT Newswires) -- OSR (OSRH) subsidiary Vaximm said Wednesday that final data from a phase 2a trial showed that its investigational vaccine VXM01 in combination with avelumab could offer meaningful clinical benefit in patients with recurrent glioblastoma, a type of aggressive brain cancer. The 25-patient trial also showed that the VXM01-avelumab combination therapy was well-tolerated and...
Scotiabank Notes Quebec's Deficit to Increase on U.S. Tariffs But Surplus Still Planned Within Five Years
Scotiabank Notes Quebec's Deficit to Increase on U.S. Tariffs But Surplus Still Planned Within Five Years
Mar 26, 2025
08:07 AM EDT, 03/26/2025 (MT Newswires) -- Quebec projects that its deficit will rise to a new record of $13.6 billion in the context of a prudent assumption that United States tariffs against Canada will expand next month, said Scotiabank. The provincial government presents an ambitious plan to return to a surplus within five years-- as required by provincial legislation...
Copyright 2023-2026 - www.financetom.com All Rights Reserved